Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: PET, ANW, MAT, MRR

Global Swine Artificial Insemination Market Analysis 2023-2030: Technological Advancements in AI Techniques Driving Industry Growth


DUBLIN, Aug. 11, 2023 /PRNewswire/ -- The "Swine Artificial Insemination Market 2023-2030" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The global swine artificial insemination market is projected to reach USD 3.16 billion by 2030, growing at a CAGR of 6.67% from 2023 to 2030.

Factors driving market growth include the increasing demand for pork products, advancements in artificial insemination technology, growing awareness about its benefits, and a focus on swine genetics. Companies like PIC, a subsidiary of Genus, are making investments in gene-edited PRRSv-resistant pigs to address disease challenges.

The market faced challenges due to the COVID-19 pandemic, African Swine Fever outbreaks, the Russia-Ukraine conflict, and macroeconomic hurdles from 2018 to 2022. However, the global demand for pork is expected to rise, boosting the adoption of artificial insemination to meet the increasing demand. Swine producers are becoming more aware of the benefits of artificial insemination, leading to improved productivity and herd health.

Factors such as sustainable food production, animal genetics, and concerns over zoonoses contribute to market growth. Swine producers are increasingly adopting artificial insemination products and services to breed disease-resistant, high-quality swine with better meat quality and feed efficiency. The market is expected to continue growing, driven by rising awareness and technological advancements.

The report highlights various market segments, with services accounting for the largest share in 2022 and semen projected to grow at the fastest rate. Normal semen held the highest share in 2022, while sexed semen is expected to grow at about 8% in the coming years. The private distribution segment had the highest market share in 2022 and is projected to grow at the fastest rate. Asia Pacific held the highest market share in 2022, while Latin America is expected to grow notably at a rate of about 7% in the near future.

Market Dynamics

The swine artificial insemination market is driven by factors like the increasing demand for pork products, advancements in technology, and supportive initiatives. On the other hand, limitations like lack of awareness and limited access to supplies and skilled labor in certain countries pose challenges to the market's growth. Overall, the market is expected to thrive in the coming years, fueled by the rising demand for pork and ongoing technological advancements in artificial insemination techniques.

Key Topics Covered

Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Swine Artificial Insemination Market Variables, Trends, & Scope
Chapter 4. Swine Artificial Insemination Market: Solutions Estimates & Trend Analysis
Chapter 5. Swine Artificial Insemination Market: Distribution Channel Estimates & Trend Analysis
Chapter 6. Swine Artificial Insemination Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/pbstvp

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]  
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 20:15
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...

at 19:34
Celltrion USA announced today that it has signed an agreement with Express Scripts, one of the nation's leading pharmacy benefit managers (PBMs) negotiating on behalf of health plans covering more than 100 million people. The agreement, effective...

at 16:48
Marc Dubrick and Lisa Becharas are bringing victories home to Boulder, Colorado, after winning their first St. Anthony's Triathlon along St. Petersburg's scenic downtown waterfront. The winners, who are teammates on The Real Triathlon Squad, raced a...

at 16:30
Nicholas Baker, M.D., Director of Robotic Thoracic Surgery at the University of Pittsburgh Medical Center (UPMC) Passavant, presented key findings from independent research at the 104th Annual Meeting of the American Association for Thoracic Surgery...

at 15:40
Sexton Lawn & Landscapes is thrilled to announce the appointment of Brooks Breland as the leading Lawn and Plant Health Expert. In this role, Breland will...

at 12:00
OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene therapy, will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th. 9...



News published on and distributed by: